What is ABT stock price today?

ABT (Abbott Laboratories) stock is trading at $89.86 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ABT stock going up or down today?

ABT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ABT stock now?

The decision to buy ABT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ABT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ABT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ABT stock overvalued or undervalued?

ABT currently trades at a P/E ratio of 24.79 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ABT is fairly priced.

What is ABT's P/E ratio?

ABT has a price-to-earnings (P/E) ratio of 24.79, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ABT's market cap?

ABT (Abbott Laboratories) has a market capitalization of $154.15 billion, making it a mid-cap stock.

What is ABT's price to book ratio?

ABT trades at a price-to-book (P/B) ratio of 3.03, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ABT pay dividends?

Yes, ABT pays dividends with a current yield of 2.69%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is ABT's dividend yield?

ABT's dividend yield is 2.69%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is ABT stock a good long-term investment?

ABT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ABT's revenue growth rate?

Revenue growth data for ABT is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ABT are available on our dashboard with complete income statement analysis.

What are the risks of investing in ABT?

Key risks for ABT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ABT compare to its competitors?

Compare ABT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ABT's performance and positioning.

What is ABT's stock price target for 2026?

Our AI model provides price targets for ABT based on fundamental analysis: Bull case $116.81 (+30%), Base case $103.33 (+15%), Bear case $80.87 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ABT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ABT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ABT's next earnings report?

ABT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ABT - Abbott Laboratories

NYSE * Healthcare * Medical Devices

$89.86

$-2.25 (-2.45%)

About Abbott Laboratories

Abbott Laboratories (ABT) common stock

Price Chart

Loading chart...

ABT Key Statistics

Market Cap

$154.15B

P/E Ratio

24.79

P/B Ratio

3.03

Dividend Yield

2.69%

How ABT Compares to Peers

P/E Rank

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
ABT(This stock)	$154.15B	24.8	0%	0.0%	-
MDTMedtronic PLC	$100.08B	20.9	0%	0.0%	vs MDT
SYKStryker Corporation	$115.45B	34.9	0%	0.0%	vs SYK
BSXBoston Scientific	$71.81B	20.2	0%	0.0%	vs BSX
ISRGIntuitive Surgical	$195.15B	80.0	0%	0.0%	vs ISRG

Data Updated: July 14, 2026 at 7:13 PM EDT

Ready to invest in ABT?

Commission-free trading available. Affiliate links.

ABT Lician Score

14% confidence

4.0/10

Neutral

ABT has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ABTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ABT Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ABT

Dashboard

Enter a ticker to analyze